Pain relief and ?decreasing fallopian tubes spasm during and after ?hysterosalpingography in infertile women ?

Comparsion of Midazolam and? ?Dexmedetomidine for pain relief and ?decreasing fallopian tubes spasm during and after ?hysterosalpingography in infertile women ?

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017081520258N57

Enrollment

102

Registered

2017-10-12

Start date

2017-05-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female infertility

Interventions

Intervention 1: Intervention group 2: We will inject 1 micro gram in kilogram Dexmedetomidin and we ?will continue drug therapy by 0/5 micro gram in kilogram Dexmedetomidine through infusion. Interven

Treatment - Drugs

Intervention group 2: We will inject 1 micro gram in kilogram Dexmedetomidin and we ?will continue drug therapy by 0/5 micro gram in kilogram Dexmedetomidine through infusion.

Intervention group 1: We will inject 0/4 milligram in kilogram Midazolam, single dose, 3-4 minute before surgery.?

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: infertility; 20 to 45 years Exclusion criteria: Contraindications for the use of Dexmethomidine and Midazolam; uterine malignancy; vaginal bleeding; history of cervical surgery; pelvic inflammation; use of any kind of pain reliever before hysterosalpingography; fallopian tubes obstruction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: During hysterosalpingography?. Method of measurement: Visual Analogue Scale.;Spasm. Timepoint: During hysterosalpingography?. Method of measurement: Graphy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

kamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026